Control of Expression of Insulin-Like Growth Factor II in Stromal Cells of Breast Cancer
Abstract
Our hypothesis is that the IGF2 gene is methylated in normal breast stromal cells, and that a decrease in methylation results in increase in stromal IGF2 expression in the breast malignancy, enhancing tumor growth. This work analyzes the biochemical mechanisms that alter methylation of the IGF2 promoter in benign stromal cells adjacent to the malignant epithelial cells in the breast tumor. The studies of this project were conducted in two systems: T6 1 breast cancer system, an ER+, PR+, IGF2 expressing breast cancer xenograft passaged in nude mice, and matched fibroblast sets from breast cancer patients. These studies could provide critical insight into stromal regulation of breast cancer and provide a new target for therapy.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jul 01, 2001
- Accession Number
- ADA397706
Entities
People
- Sahana S. Kaup
Organizations
- Georgetown University